<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Akari Therapeutics Plc (AKTX) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/aktx/filings</link>
    <description>Latest company filings for Akari Therapeutics Plc (AKTX) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Fri, 10 Jul 2026 02:17:56 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/aktx/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[AKTX: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226025051/formpre14a.htm</link>
      <guid isPermaLink="false">0001493152-26-025051</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a PRE 14A (PRE 14A) on 2026-05-22.]]></description>
      <pubDate>Fri, 22 May 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226025037/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-26-025037</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2026-05-22.]]></description>
      <pubDate>Fri, 22 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: RW]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226024741/formrw.htm</link>
      <guid isPermaLink="false">0001493152-26-024741</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a RW (RW) on 2026-05-21.]]></description>
      <pubDate>Thu, 21 May 2026 12:00:00 GMT</pubDate>
      <category>RW</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226024446/form10-q.htm</link>
      <guid isPermaLink="false">0001493152-26-024446</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Quarterly report (10-Q) on 2026-05-19.]]></description>
      <pubDate>Tue, 19 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AKTX: NT 10-Q]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226024230/formnt10-q.htm</link>
      <guid isPermaLink="false">0001493152-26-024230</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a NT 10-Q (NT 10-Q) on 2026-05-18.]]></description>
      <pubDate>Mon, 18 May 2026 12:00:00 GMT</pubDate>
      <category>NT 10-Q</category>
    </item>
    <item>
      <title><![CDATA[AKTX: IPO registration (S-1)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226022019/forms-1.htm</link>
      <guid isPermaLink="false">0001493152-26-022019</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a IPO registration (S-1) on 2026-05-08.]]></description>
      <pubDate>Fri, 08 May 2026 12:00:00 GMT</pubDate>
      <category>S-1</category>
    </item>
    <item>
      <title><![CDATA[AKTX: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/999999999526001192/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-001192</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a EFFECT (EFFECT) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[AKTX: POS AM]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226016154/formposam.htm</link>
      <guid isPermaLink="false">0001493152-26-016154</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a POS AM (POS AM) on 2026-04-10.]]></description>
      <pubDate>Fri, 10 Apr 2026 12:00:00 GMT</pubDate>
      <category>POS AM</category>
    </item>
    <item>
      <title><![CDATA[AKTX: DRS]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226014977/filename1.htm</link>
      <guid isPermaLink="false">0001493152-26-014977</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a DRS (DRS) on 2026-04-02.]]></description>
      <pubDate>Thu, 02 Apr 2026 12:00:00 GMT</pubDate>
      <category>DRS</category>
    </item>
    <item>
      <title><![CDATA[AKTX: F-6/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000091957426001972/d12123390_f-6a.htm</link>
      <guid isPermaLink="false">0000919574-26-001972</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a F-6/A (F-6/A) on 2026-03-31.]]></description>
      <pubDate>Tue, 31 Mar 2026 12:00:00 GMT</pubDate>
      <category>F-6/A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226013664/form10-k.htm</link>
      <guid isPermaLink="false">0001493152-26-013664</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Annual report (10-K) on 2026-03-30.]]></description>
      <pubDate>Mon, 30 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226010602/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-26-010602</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2026-03-17.]]></description>
      <pubDate>Tue, 17 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226010304/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-26-010304</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226008880/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001493152-26-008880</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: SCHEDULE 13D/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226008874/xslSCHEDULE_13D_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001493152-26-008874</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a SCHEDULE 13D/A (SCHEDULE 13D/A) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13D/A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226008873/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001493152-26-008873</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226008570/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-26-008570</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226004754/formdef14a.htm</link>
      <guid isPermaLink="false">0001493152-26-004754</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Proxy statement (DEF 14A) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/999999999526000356/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-26-000356</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a EFFECT (EFFECT) on 2026-01-29.]]></description>
      <pubDate>Thu, 29 Jan 2026 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226003763/filename1.htm</link>
      <guid isPermaLink="false">0001493152-26-003763</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Company correspondence (CORRESP) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[AKTX: SEC correspondence (UPLOAD)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000000000026000815/filename1.pdf</link>
      <guid isPermaLink="false">0000000000-26-000815</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a SEC correspondence (UPLOAD) on 2026-01-27.]]></description>
      <pubDate>Tue, 27 Jan 2026 12:00:00 GMT</pubDate>
      <category>UPLOAD</category>
    </item>
    <item>
      <title><![CDATA[AKTX: IPO registration (S-1)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226003458/forms-1.htm</link>
      <guid isPermaLink="false">0001493152-26-003458</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a IPO registration (S-1) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>S-1</category>
    </item>
    <item>
      <title><![CDATA[AKTX: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315226003252/formpre14a.htm</link>
      <guid isPermaLink="false">0001493152-26-003252</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a PRE 14A (PRE 14A) on 2026-01-22.]]></description>
      <pubDate>Thu, 22 Jan 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028422/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028422</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028421/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028421</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028420/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028420</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028419/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028419</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028418/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028418</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028417/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028417</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028416/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-028416</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-12-18.]]></description>
      <pubDate>Thu, 18 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028075/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-028075</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-12-17.]]></description>
      <pubDate>Wed, 17 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225028073/form424b5.htm</link>
      <guid isPermaLink="false">0001493152-25-028073</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Prospectus supplement (424B5) on 2025-12-17.]]></description>
      <pubDate>Wed, 17 Dec 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225027969/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-027969</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-12-16.]]></description>
      <pubDate>Tue, 16 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225026533/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-026533</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-12-08.]]></description>
      <pubDate>Mon, 08 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: 424B3]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225026387/form424b3.htm</link>
      <guid isPermaLink="false">0001493152-25-026387</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a 424B3 (424B3) on 2025-12-05.]]></description>
      <pubDate>Fri, 05 Dec 2025 12:00:00 GMT</pubDate>
      <category>424B3</category>
    </item>
    <item>
      <title><![CDATA[AKTX: EFFECT]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/999999999525003483/xslEFFECTX01/primary_doc.xml</link>
      <guid isPermaLink="false">9999999995-25-003483</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a EFFECT (EFFECT) on 2025-12-02.]]></description>
      <pubDate>Tue, 02 Dec 2025 12:00:00 GMT</pubDate>
      <category>EFFECT</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Company correspondence (CORRESP)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225025537/filename1.htm</link>
      <guid isPermaLink="false">0001493152-25-025537</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Company correspondence (CORRESP) on 2025-12-01.]]></description>
      <pubDate>Mon, 01 Dec 2025 12:00:00 GMT</pubDate>
      <category>CORRESP</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225025177/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-025177</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-11-26.]]></description>
      <pubDate>Wed, 26 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225023911/formdef14a.htm</link>
      <guid isPermaLink="false">0001493152-25-023911</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Proxy statement (DEF 14A) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: IPO registration (S-1)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225023908/forms-1.htm</link>
      <guid isPermaLink="false">0001493152-25-023908</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a IPO registration (S-1) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>S-1</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225022390/form10-q.htm</link>
      <guid isPermaLink="false">0001493152-25-022390</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Quarterly report (10-Q) on 2025-11-13.]]></description>
      <pubDate>Thu, 13 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AKTX: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225021316/formpre14a.htm</link>
      <guid isPermaLink="false">0001493152-25-021316</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a PRE 14A (PRE 14A) on 2025-11-07.]]></description>
      <pubDate>Fri, 07 Nov 2025 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225020753/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-020753</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-11-04.]]></description>
      <pubDate>Tue, 04 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225019194/xslF345X05/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-019194</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Insider trade (4) on 2025-10-24.]]></description>
      <pubDate>Fri, 24 Oct 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKTX: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225019192/xslF345X02/ownership.xml</link>
      <guid isPermaLink="false">0001493152-25-019192</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a New insider ownership (3) on 2025-10-24.]]></description>
      <pubDate>Fri, 24 Oct 2025 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AKTX: D]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225019187/xslFormDX01/primary_doc.xml</link>
      <guid isPermaLink="false">0001493152-25-019187</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a D (D) on 2025-10-24.]]></description>
      <pubDate>Fri, 24 Oct 2025 12:00:00 GMT</pubDate>
      <category>D</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225019112/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-019112</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-10-23.]]></description>
      <pubDate>Thu, 23 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225018269/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-018269</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-10-16.]]></description>
      <pubDate>Thu, 16 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225018268/form424b5.htm</link>
      <guid isPermaLink="false">0001493152-25-018268</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Prospectus supplement (424B5) on 2025-10-16.]]></description>
      <pubDate>Thu, 16 Oct 2025 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[AKTX: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1541157/000149315225018091/form8-k.htm</link>
      <guid isPermaLink="false">0001493152-25-018091</guid>
      <description><![CDATA[Akari Therapeutics Plc filed a Major company event (8-K) on 2025-10-15.]]></description>
      <pubDate>Wed, 15 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
  </channel>
</rss>